Physician profile
John D Robb
NPI 1962844621
$5,370.25
in general payments reported to CMS, 2019-2025
10 companies · $93.09 in 2025
The $93.09 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $4,233 · 2021: $161 · 2022: $93.76 · 2023: $155 · 2024: $394 · 2025: $93.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $1,936.69 | 2020 | |
| W. L. Gore & Associates, INC. | $1,518.87 | 2020-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Atricure, INC. | $831.85 | 2019-2020 | |
| Baxter Healthcare | $361.16 | 2019-2024 | Floseal, Tisseel, Coseal |
| Medtronic, INC. | $295.37 | 2021-2023 | Corevalve Evolut R |
| Boston Scientific Corporation | $162.47 | 2020 | |
| Penumbra, INC. | $125.00 | 2020 | |
| Abiomed | $95.05 | 2023-2025 | Impella |
| Abbott Laboratories | $23.95 | 2019 | |
| Ethicon US, LLC | $19.84 | 2025 | Stratafix, Surgicel Nu-Knit, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Robb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.